These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31072407)

  • 21. Tiotropium: an inhaled anticholinergic for chronic obstructive pulmonary disease.
    Olin JL
    Am J Health Syst Pharm; 2005 Jun; 62(12):1263-9. PubMed ID: 15947126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients.
    Yoshimura K; Maekura R; Hiraga T; Kitada S; Miki K; Miki M; Tateishi Y
    Int J Chron Obstruct Pulmon Dis; 2012; 7():109-17. PubMed ID: 22615527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of inhaled anticholinergic agents in obstructive airway disease.
    Restrepo RD
    Respir Care; 2007 Jul; 52(7):833-51. PubMed ID: 17594728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fast onset of action of glycopyrronium compared with tiotropium in patients with moderate to severe COPD - A randomised, multicentre, crossover trial.
    Watz H; Mailänder C; May C; Baier M; Kirsten AM
    Pulm Pharmacol Ther; 2017 Feb; 42():13-20. PubMed ID: 27940287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tiotropium versus salmeterol in COPD.
    Oba Y
    N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714654
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.
    Calverley PM; Lee A; Towse L; van Noord J; Witek TJ; Kelsen S
    Thorax; 2003 Oct; 58(10):855-60. PubMed ID: 14514937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease.
    Buhl R; Magder S; Bothner U; Tetzlaff K; Voß F; Loaiza L; Vogelmeier CF; McGarvey L
    Respir Med; 2017 Jan; 122():58-66. PubMed ID: 27993292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term bronchodilator inhaled therapy in COPD: the role of tiotropium bromidum.
    Antoniu SA
    Rev Recent Clin Trials; 2009 May; 4(2):89-98. PubMed ID: 19463105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial.
    Vestbo J; Papi A; Corradi M; Blazhko V; Montagna I; Francisco C; Cohuet G; Vezzoli S; Scuri M; Singh D
    Lancet; 2017 May; 389(10082):1919-1929. PubMed ID: 28385353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of anticholinergics in chronic obstructive pulmonary disease.
    Barnes PJ
    Am J Med; 2004 Dec; 117 Suppl 12A():24S-32S. PubMed ID: 15693640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease?
    Reddy CB; Kanner RE
    Drugs Aging; 2007; 24(8):615-28. PubMed ID: 17702532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of inhaled anticholinergics in chronic obstructive pulmonary disease: is there cause for concern? A review of evidence from clinical trials.
    Sindi A; McIvor A
    Pol Arch Med Wewn; 2009; 119(1-2):74-8. PubMed ID: 19341182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchodilator Effect of Tiotropium via Respimat
    Ogasawara T; Sakata J; Aoshima Y; Tanaka K; Yano T; Kasamatsu N
    Intern Med; 2017 Sep; 56(18):2401-2406. PubMed ID: 28824055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease].
    Ma J; Zhou Z; Tang Y; Zhong N
    Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):964-8. PubMed ID: 25623564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
    Vogelmeier C; Hederer B; Glaab T; Schmidt H; Rutten-van Mölken MP; Beeh KM; Rabe KF; Fabbri LM;
    N Engl J Med; 2011 Mar; 364(12):1093-1103. PubMed ID: 21428765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhaled anticholinergics and the long-term treatment of chronic obstructive pulmonary disease: Weighing benefits and risks.
    Hogarth DK; Jacobson TA
    Clin Cornerstone; 2009; 9(3):45-9. PubMed ID: 19781515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methods.
    Kwak MS; Kim E; Jang EJ; Kim HJ; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2365-76. PubMed ID: 26604734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled tiotropium for stable chronic obstructive pulmonary disease.
    Barr RG; Bourbeau J; Camargo CA; Ram FS
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002876. PubMed ID: 15846642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.
    Somand H; Remington TL
    Ann Pharmacother; 2005 Sep; 39(9):1467-75. PubMed ID: 16030078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.
    Casaburi R; Kukafka D; Cooper CB; Witek TJ; Kesten S
    Chest; 2005 Mar; 127(3):809-17. PubMed ID: 15764761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.